On 10 patients, suffering from peripheral arterial disease, with critical limb ischaemia, the CO2 production during ischaemia has been evaluated at 1st and at 28th day of treatment with iloprost. The study demonstrated that the drug is able to improve the tissue resistance to ischaemia, with a significant (p<0.05) reduction of the CO2 production. The authors underline that this study is one of the first confirmations, in vivo and on the man, of the previous experimental findings, made in isolated arterial tissue
Iloprost, stable analogue of the prostacyclin, is able to improve the tissue resistance to ischaemia
DI PINO, Luigi;SIGNORELLI, Salvatore
1994-01-01
Abstract
On 10 patients, suffering from peripheral arterial disease, with critical limb ischaemia, the CO2 production during ischaemia has been evaluated at 1st and at 28th day of treatment with iloprost. The study demonstrated that the drug is able to improve the tissue resistance to ischaemia, with a significant (p<0.05) reduction of the CO2 production. The authors underline that this study is one of the first confirmations, in vivo and on the man, of the previous experimental findings, made in isolated arterial tissueFile in questo prodotto:
File | Dimensione | Formato | |
---|---|---|---|
International angiology--1994.pdf
solo gestori archivio
Tipologia:
Versione Editoriale (PDF)
Dimensione
155 kB
Formato
Adobe PDF
|
155 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.